PDF herunterladen
CC BY-NC-ND 4.0 · Indian J Plast Surg 2021; 54(04): 521-526
DOI: 10.1055/s-0041-1740289
Review Article

COVID-19 Infection: Impact on Hair

Sandeep Suresh Sattur
1   Hairrevive-Centre for Hair Restoration & Skin Rejuvenation, Santacruz West, Mumbai, Maharashtra, India
,
Indu Sandeep Sattur
1   Hairrevive-Centre for Hair Restoration & Skin Rejuvenation, Santacruz West, Mumbai, Maharashtra, India
› Institutsangaben
› Weitere Informationen
Auch verfügbar auf
   Lizenzen und Reprints

Abstract

With a practice dedicated to hair restoration and hair loss management, the authors have seen a large number of patients presenting with increased hair fall in the last 18 months. Hair fall after a stressfull event such as infections with febrile episodes is known. However, the latent period between the infective episode and hair fall has been shorter after COVID-19 infection than before. This review attempts to look at various pathways responsible for hair fall and if this differs from the conventional hair fall seen after any infection. It also tries to understand if the infection with the SARS-CoV-2 virus has a direct impact on the hair follicle leading to hair fall.

Keywords

hair fall - COVID-19 - Hair follicle


Publikationsverlauf

Artikel online veröffentlicht:
13. Dezember 2021

© 2021. Association of Plastic Surgeons of India. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 2020; 5 (04) 536-544 DOI: 10.1038/s41564-020-0695-z.
    CrossrefPubMedGoogle Scholar
  • 2 Cascella M, Rajnik M, Aleem A. et al. Features, Evaluation, and Treatment of Coronavirus (COVID-19) [Updated 2021 Jul 17]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021. Accessed November 17, 2021 from: https://www.ncbi.nlm.nih.gov/books/NBK554776/
    Google Scholar
  • 3 Parasher A. COVID-19: Current understanding of its pathophysiology, clinical presentation and treatment. Postgrad Med J 2021; 97 (1147): 312-320
    CrossrefPubMedGoogle Scholar
  • 4 https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports
  • 5 Xiong Q, Xu M, Li J. et al. Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clin Microbiol Infect 2021; 27 (01) 89-95
    CrossrefPubMedGoogle Scholar
  • 6 Mieczkowska K, Deutsch A, Borok J. et al. Telogen effluvium: a sequela of COVID-19. Int J Dermatol 2021; 60 (01) 122-124
    CrossrefPubMedGoogle Scholar
  • 7 Olds H, Liu J, Luk K, Lim HW, Ozog D, Rambhatla PV. Telogen effluvium associated with COVID-19 infection. Dermatol Ther (Heidelb) 2021; 34 (02) e14761
    PubMedGoogle Scholar
  • 8 Rizzetto G, Diotallevi F, Campanati A. et al. Telogen effluvium related to post severe Sars-Cov-2 infection: clinical aspects and our management experience. Dermatol Ther (Heidelb) 2021; 34 (01) e14547
    PubMedGoogle Scholar
  • 9 Lv S, Wang L, Zou X. et al. A case of acute telogen effluvium after SARS-CoV-2 infection. Clin Cosmet Investig Dermatol 2021; 14: 385-387
    CrossrefPubMedGoogle Scholar
  • 10 Recalcati S. Cutaneous manifestations in COVID-19: a first perspective. J Eur Acad Dermatol Venereol 2020; 34 (05) e212-e213
    CrossrefPubMedGoogle Scholar
  • 11 Fatemeh S, Bahareh H. et al. COVID-19 and skin manifestations: an overview of case reports/case series and meta-analysis of prevalence studies. JOURNAL Frontiers in Medicine 2020; 7: 651
    Google Scholar
  • 12 Sachdeva M, Gianotti R, Shah M. et al. Cutaneous manifestations of COVID-19: Report of three cases and a review of literature. J Dermatol Sci 2020; 98 (02) 75-81
    CrossrefPubMedGoogle Scholar
  • 13 Jia JL, Kamceva M, Rao SA, Linos E. Cutaneous manifestations of COVID-19: a preliminary review. J Am Acad Dermatol 2020; 83 (02) 687-690
    CrossrefPubMedGoogle Scholar
  • 14 Genovese G, Moltrasio C, Berti E, Marzano AV. Skin manifestations associated with COVID-19: current knowledge and future perspectives. Dermatology 2021; 237 (01) 1-12
    CrossrefPubMedGoogle Scholar
  • 15 Deshmukh V, Motwani R, Kumar A, Kumari C, Raza K. Histopathological observations in COVID-19: a systematic review. J Clin Pathol 2021; 74 (02) 76-83
    CrossrefPubMedGoogle Scholar
  • 16 Trüeb RM, Dutra Rezende H, Gavazzoni Dias MFR. What can the hair tell us about COVID-19?. Exp Dermatol 2021; 30 (02) 288-290
    CrossrefPubMedGoogle Scholar
  • 17 Shanshal M. COVID-19 related anagen effluvium. J Dermatolog Treat 2020; 1-2 DOI: 10.1080/09546634.2020.1792400.
    CrossrefPubMedGoogle Scholar
  • 18 Salamanna F, Maglio M, Landini MP, Fini M. Body localization of ACE-2: on the trail of the keyhole of SARS-CoV-2. Front Med (Lausanne) 2020; 7: 594495
    CrossrefPubMedGoogle Scholar
  • 19 Saponaro F, Rutigliano G, Sestito S. et al. ACE2 in the era of SARS-CoV-2: controversies and novel perspectives. Front Mol Biosci 2020; 7: 588618
    CrossrefPubMedGoogle Scholar
  • 20 Radzikowska U, Ding M, Tan G. et al. Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors. Allergy 2020; 75 (11) 2829-2845
    CrossrefPubMedGoogle Scholar
  • 21 Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol 2004; 203 (02) 631-637
    CrossrefPubMedGoogle Scholar
  • 22 Rossi A, Magri F, Sernicola A. et al. Telogen effluvium after SARS-CoV-2 infection: a series of cases and possible pathogenetic mechanisms. Skin Appendage Disord 2021; 21: 1-5
    PubMedGoogle Scholar
  • 23 Tirado SM, Yoon KJ. Antibody-dependent enhancement of virus infection and disease. Viral Immunol 2003; 16 (01) 69-86
    CrossrefPubMedGoogle Scholar
  • 24 Ulrich H, Pillat MM, Tárnok A. Dengue fever, COVID-19 (SARS-CoV-2), and antibody-dependent enhancement (ADE): a perspective. Cytometry A 2020; 97 (07) 662-667
    CrossrefPubMedGoogle Scholar
  • 25 Hajela K. Structure and function of Fc receptors. Biochem Educ 1991; 19 (02) 50-57 ISSN 0307–4412
    CrossrefGoogle Scholar
  • 26 Wei KC, Huang MS, Tsung-Hsien C. Dengue VIPHHFDPC. Front Cell Infect Microbiol 2018; 8: 268
    CrossrefPubMedGoogle Scholar
  • 27 Okamoto T, Suzuki T, Kusakabe S. et al. Regulation of apoptosis during flavivirus infection. Viruses 2017; 9 (09) 243
    CrossrefPubMedGoogle Scholar
  • 28 Abrantes TF, Artounian KA, Falsey R. et al. Time of onset and duration of post-COVID-19 acute telogen effluvium. J Am Acad Dermatol 2021; 85 (04) 975-976 [published online ahead of print, 2021 Jul 21]
    CrossrefPubMedGoogle Scholar
  • 29 Gohary YM, Abdel Fattah DS. Detection of tumor necrosis factor-alpha in nonlesional tissues of alopecia areata patients: a prove for a systemic disease. Int J Trichology 2017; 9 (04) 154-159
    CrossrefPubMedGoogle Scholar
  • 30 Kanwar AJ, Narang T. Anagen effluvium. Indian J Dermatol Venereol Leprol 2013; 79 (05) 604-612
    CrossrefPubMedGoogle Scholar
  • 31 Gianotti R, Zerbi P, Dodiuk-Gad RP. Clinical and histopathological study of skin dermatoses in patients affected by COVID-19 infection in the Northern part of Italy. J Dermatol Sci 2020; 98 (02) 141-143
    CrossrefPubMedGoogle Scholar
  • 32 Magro C, Mulvey JJ, Berlin D. et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. Transl Res 2020; 220: 1-13
    CrossrefPubMedGoogle Scholar
  • 33 Watras MM, Patel JP, Arya R. Traditional anticoagulants and hair loss: a role for direct oral anticoagulants? A review of the Literature. Drugs Real World Outcomes 2016; 3 (01) 1-6
    CrossrefPubMedGoogle Scholar
  • 34 Vaughn VM, Yost M, Abshire C. et al. Trends in venous thromboembolism anticoagulation in patients hospitalized with COVID-19. JAMA Netw Open 2021; 4 (06) e2111788
    CrossrefPubMedGoogle Scholar
  • 35 Luo M, Guo L, Yu M, Jiang W, Wang H. The psychological and mental impact of coronavirus disease 2019 (COVID-19) on medical staff and general public - a systematic review and meta-analysis. Psychiatry Res 2020; 291: 113190
    CrossrefPubMedGoogle Scholar
  • 36 Rajkumar RP. COVID-19 and mental health: a review of the existing literature. Asian J Psychiatr 2020; 52: 102066
    CrossrefPubMedGoogle Scholar
  • 37 Brooks SK, Webster RK, Smith LE. et al. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet 2020; 395 (10227) 912-920
    CrossrefPubMedGoogle Scholar
  • 38 Nguyen H, Tran N. et al. Perceived stress of quarantine and isolation during COVID-19 pandemic: a global survey. Frontiers in Psychiatry, Volume 2021; 12: 651
    Google Scholar
  • 39 Botchkarev VA. Stress and the hair follicle: exploring the connections. Am J Pathol 2003; 162 (03) 709-712
    CrossrefPubMedGoogle Scholar
  • 40 Chu B, Marwaha K, Sanvictores T. et al. Physiology, Stress Reaction. [Updated 2021 Jun 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021. Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK541120/
    Google Scholar
  • 41 Peters EMJ, Müller Y, Snaga W. et al. Hair and stress: a pilot study of hair and cytokine balance alteration in healthy young women under major exam stress. PLoS One 2017; 12 (04) e0175904
    CrossrefPubMedGoogle Scholar
  • 42 Hadshiew IM, Foitzik K, Arck PC, Paus R. Burden of hair loss: stress and the underestimated psychosocial impact of telogen effluvium and androgenetic alopecia. J Invest Dermatol 2004; 123 (03) 455-457
    CrossrefPubMedGoogle Scholar
  • 43 FIvenson D. COVID-19: association with rapidly progressive forms of alopecia areata. Int J Dermatol 2021; 60 (01) 127
    CrossrefPubMedGoogle Scholar
  • 44 Malkud S. Telogen effluvium: a review. J Clin Diagn Res 2015; 9 (09) WE01-WE03
    CrossrefPubMedGoogle Scholar
  • 45 Grover C, Khurana A. Telogen effluvium. Indian J Dermatol Venereol Leprol 2013; 79 (05) 591-603
    CrossrefPubMedGoogle Scholar
  • 46 Rebora A. Telogen effluvium: a comprehensive review. Clin Cosmet Investig Dermatol 2019; 12: 583-590
    CrossrefPubMedGoogle Scholar
  • 47 McDonald KA, Shelley AJ, Colantonio S, Beecker J. Hair pull test: evidence-based update and revision of guidelines. J Am Acad Dermatol 2017; 76 (03) 472-477
    CrossrefPubMedGoogle Scholar
  • 48 Jain N, Doshi B, Khopkar U. Trichoscopy in alopecias: diagnosis simplified. Int J Trichology 2013; 5 (04) 170-178 DOI: 10.4103/0974-7753.130385.
    CrossrefPubMedGoogle Scholar